美國居民不適用 XM 服務。
A
A

Amphenol

交易方向

交易者脈動

技術摘要

小時

財經新聞

US court's reversal of 'Chevron deference' may limit investments in EVs, safer chemicals, Jefferies says

US court's reversal of 'Chevron deference' may limit investments in EVs, safer chemicals, Jefferies says July 11 (Reuters) - The U.S. Supreme Court's recent decision to overturn a 1984 precedent, which allowed government agencies to interpret unclear laws, could curb investments in electric vehicles and the development of safer chemicals used in manufacturing, according to a Jefferies analyst.
C
X
A
T

U.S. Nvidia, Qualcomm, Tesla

U.S. RESEARCH ROUNDUP-Nvidia, Qualcomm, Tesla July 10 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Nvidia, Qualcomm and Tesla, on Wednesday. HIGHLIGHTS * Brighthouse Financial Inc BHF.O : Jefferies raises to buy from hold * Legalzoom.Com Inc LZ.O : JP Morgan cuts to neutral from overweight * Nvidia Corp NVDA.O : KeyBanc raises target price to $180 * Qualcomm Inc QCOM.O : KeyBanc raises target price to $225 * Tesla
A
A
A
A
A
C
G
M
M
N
P
Q
S
T
A
A
A
C
O
B
T
A
A
A
A
C
G
L
U

U.S. Ardelyx, Eli Lilly, Tesla

U.S. RESEARCH ROUNDUP-Ardelyx, Eli Lilly, Tesla July 3 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Ardelyx, Eli Lilly and Tesla, on Wednesday. HIGHLIGHTS * Ardelyx Inc ARDX.O : Piper Sandler cuts to neutral from overweight * Eli Lilly LLY.N : Jefferies raises target price to $1,041 from $1,015 * Nicolet Bankshares Inc NIC.N : Stephens raises target price to $90 from $88 * Tesla Inc TSLA.O : Wedbush raises target
A
C
C
C
H
I
J
M
T
C
F
D
A
C
M

U.S. Avidity Biosciences, Broadcom, Cara Therapeutics

U.S. RESEARCH ROUNDUP-Avidity Biosciences, Broadcom, Cara Therapeutics June 13 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Avidity Biosciences, Broadcom and Cara Therapeutics, on Thursday. HIGHLIGHTS * Avidity Biosciences Inc RNA.O : Leerink Partners raises target price to $56 from $38 * Broadcom Inc AVGO.O : TD Cowen raises target price to $1,750 from $1,500 * Cara Therapeutics Inc CARA.O : Canaccord Genuity cut
B
B
C
C
G
M
C
A
D
I
L

U.S. Chord Energy, PVH, Saia

U.S. RESEARCH ROUNDUP-Chord Energy, PVH, Saia June 6 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Chord Energy, PVH and Saia, on Thursday. HIGHLIGHTS * Chord Energy Corp CHRD.O : Gerdes Energy Research raises to buy from neutral * Costco Wholesale Corp COST.O : Oppenheimer raises target price to $905 from $850 * PVH Corp PVH.N : Barclays raises target price to $154 from $149 * Saia Inc SAIA.O : TD Cowen raises tar
A
A
C
I
C
D
D
T
E
X
A
C
P

細節

熱門資產

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明